West Virginia Pharmacy Laws

Below is a list of links to current West Virginia Code (on the Legislature's web site) and West Virginia Code of State Rules (on the Secretary of State's web site) governing the practice of pharmacy. If you wish to view a particular provision, click on the link and perform the required search on the linked site.

• West Virginia Code Sec 30-5-1, et seq., creates the Board of Pharmacy, provides for its powers and duties generally, and sets forth requirements for licensure and permitting of Pharmacists, Pharmacy Technicians, Pharmacy Interns, and Pharmacies. 

• West Virginia Code Chapter 60A, Uniform Controlled Substances Act. 

• (a)  Board of Pharmacy Rules, Title 15 of the CSR, Series 1 through 13.  In "Type Title" field of the search box, type "15"; in the "Type A Name" field, put "Pharmacy".

• (b) Board of Medicine, Board of Osteopathy, and Board of Pharmacy Joint Rules for Collaborative Pharmacy Practice, Title 11, Series  8.

• West Virginia Code Generally.

• DEA law links.

• Code of Federal Regulations (CFR) Main Page.

  
  
  quoted from here

West Virginia Board of Pharmacy Next Meeting Agenda July 7-8, 2013

• Pharmacy Board Meeting, July 7-8, 2013, Morgantown, WV
• Pharmacy Board Meeting - July 8, 2013 8:00 a.m. - West Virginia University, School of Pharmacy

Agenda for Pharmacy Board Meeting, July 7-8, 2013, Morgantown, WV
Download Agenda

West Virginia Board of Pharmacy Agenda for Meeting March 24, 2013--Discussion Included Compounding for Office Use and Whether allowed

AGENDA

Morgantown, West Virginia
Sunday, March 24, 2013
5:00 P.M. Marriott Residence Inn, Conference room.
1. Approval of December 16-17, 2012, Board Minutes.

2. Complaint Committee disciplinary recommendations. (Executive Session: Complaint Committee to address).

3. Building Renovation Update (Bid Process) (Executive Session: No Handout).

Recess.
Continue meeting on 3/25/13 at 8:00 a.m., at WVU School of Pharmacy, Room 1131 Conference Room.

Re-Adjourn
Morgantown, West Virginia
Monday, March 25, 2013
8:00 A.M. WVU School of Pharmacy, Rm 1131Continued from 3/25/12

4. Consider Petition from Rite Aid for Declaratory Ruling and supporting proffer of evidence, seeking similar ruling as Kroger and Walgreen’s received concerning application of WV Code § 30-5-12b and generic substitution pricing language to cash transactions versus dispensings covered in whole or in part by insurance.

5. Request of Amy Crabtree to accept University of Kentucky College of Pharmacy Immunizations Training for pharmacist immunizations in lieu of APHA training.

6. Request of Dr. Clinton Sloan, DO, for Board to consider language in future rulemaking to state “ONLY IF NEEDED” on labeling rather than “prn” or “as needed”.

7. Request of applicant Steven Christopher Green for reciprocity for pharmacist license from Ohio, with prior discipline in Ohio to be considered.

8. Request of Medical Arts Pharmacy about the legality of using labeled multi-dose bubble packs and other containers for dispensing to ambulatory patients, with request for consideration of Rule 15-1-24 regarding use of specialized dispensing systems in health
institutions. Definition of “dispensing”, labeling requirements and other issues applying to the situation to be considered as well.

9. Request from Pharmacy Technician University to approve their Pharmacy Technician training course for use by any pharmacy to train their technician trainees.

10. Recommendations of the CPE Committee for changes to CPE rules in 15-3-1, et seq., for required continuing pharmacy education related to SB 437 (2012) for “drug diversion training and best practice prescribing of controlled substances training” and other clean-up.

11. Attendees and Delegate Selection at upcoming NABP Annual Meeting, May 18-21, 2013, St. Louis, MO.

12. Compounding for office use: permitted or disallowed in West Virginia?

13. Review of pending legislation of interest to the Board introduced during the Regular 2013 Legislative Session, including, but not limited to,
-HB 2577, the Pharmacy Practice Act;
-SB 11, changes to the controlled substances schedules (including whether hydrocodone in all forms and combinations should be a schedule II, or remain in Schedule III with or without further restrictions);
- SB 27, naloxone in emergency situations;
- HB 2729, epinephrine in emergency situations in schools, (SB 23 general use);
- SB 201, expedited partner therapy when encountering STD diagnoses;
- HB 2584, removing account sweeps language from Chapter 30, Article 1; and
- Board Rules and other legislation impacting directly on the practice of pharmacy or operation of the Board.

14. Any other business.

15. Schedule of next Board Meeting.

Adjourn.

West Virginia Board of Pharmacy December Board Meeting Addresses Compounding Issue

AGENDA

Sunday, December 16, 2012 5:00 P.M., and
Monday, December 17, 2012 8:00 A.M., at
Board of Accountancy Conference Room
106 Capitol Street, Charleston, West Virginia
1.     Approval of Minutes of the West Virginia Board of Pharmacy, September 7-8, 2012, and October 9, 2012 meetings.

2.     Complaint Committee Report of disciplinary recommendations. (Executive Session: Complaint Committee to address).

3.     Building Renovation Update. (Executive Session: Discussion of proposed bid documents, budget, and other such matters). (No handouts).
Continue meeting on 12/17/12 at 8:00 a.m.

Charleston, West Virginia
Monday, December 17, 2012, 8:00 A.M.
(Continued from Sunday, December 16, 2012)

4.     Request of Dave Cailler to regarding reciprocation from “original” state of licensure.

5.     Consideration of compounding of prescription medications and the rules of the Board protecting public safety in light of the recent issues with the Massachusetts pharmacy, New England Compounding Center. Roger Shallis to attend December 19 intergovernmental working meeting held by Department Of Health And Human Services, Food and Drug Administration, in Silver Spring, MD.

6.     Update and presentation of an award by the West Virginia Pharmacy Recovery Network, Executive Director Mike Brown. (No handouts).

7.     Request of Omnicare of Morgantown, Chris Lockard, requesting the Board review and, if appropriate, approve of, Omnicare’s plan for mail order dispensing from its Cincinnati facility to long term care facilities in West Virginia.

8.     Consideration of whether to approach Boards of Medicine and Osteopathy about revising statutes or rules and procedures for Collaborative Practice by pharmacists. (No handouts).

9.     Consideration of Practice Act legislation likely to be introduced in the Legislature in 2013, whether to try to move the bill with or without changes to generic pricing substitute language in § 30-5-12b, and other such issues. (No handouts).

10.   Controlled Substances Monitoring Program update (Michael Goff, CSMP Administrator). (No handouts).

11.   Update on implementation of Pseudoephedrine NPLEx tracking system. (Michael Goff, CSMP Administrator). (No handouts).

12.   Consideration of issuance of wholesale distributor’s licenses, and whether they include controlled substances handling permits or not within the fee of $750.00.

13.   Meeting with Board’s outside counsel, Jeff Wakefield, Danielle Waltz Swann, and firm of Flaherty Sensabaugh Bonasso for update on and consideration of State of West Virginia, ex. Rel. Darrell V. McGraw, Jr., Attorney General, v. West Virginia Board of Pharmacy, Civil Action No. 12 Misc. 537, Amended Petition for Writ of Prohibition against the Board. (Executive Session, Attorney-Client Priveleged Discussions)

14.   Announcements and any other business.

15.   Schedule next Board Meeting.

Adjourn.
Source found here